Desired cells are isolated using positive magnetic isolation of CD34 from cord blood. CD34+ cells are targeted using uniform, superparamagnetic polymer beads coated with a primary monoclonal antibody specific for the CD34 membrane antigen predominantly

CD34 is a glycosylated transmembrane protein and represents a well-known marker for primitive blood-and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial stem cells. CD34+ stem cells are multipotent and can differentiate to all

CD34 is a glycosylated transmembrane protein and represents a well-known marker for primitive blood-and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial stem cells. CD34+ stem cells are multipotent and can give rise to

CD34 is most commonly associated with expression on hematopoietic progenitor cells found in bone marrow and cord blood. While compromising only 1.5% of bone marrow mononuclear cell population, CD34 stem cells are multipotent and responsible

Cord blood CD34+ stem cells are isolated using positive immunomagnetic cell separation procedures from umbilical cord blood

Cryopreserved ampule of Human Cord Blood CD34+ stem/progenitors containing ≥1 million cells

CD34+ stem cells are multipotent and can give rise to all cell types in blood. CD34 cells are most known for its expression on hematopoietic progenitor cells found in bone marrow and cord blood. While

CD34+ stem cells are multipotent and can give rise to all cell types in blood. CD34 cells are most known for its expression on hematopoietic progenitor cells found in bone marrow and cord blood. While